Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs
Felip, E., Shaw, A. T., Bearz, A., Camidge, D. R., Solomon, B. J., Bauman, J. R., . . . Besse, … Read More
